Avalon GloboCare Corp.

1.23-0.0100-0.81%Vol 295.62K1Y Perf -26.36%
Jun 15th, 2021 16:00 DELAYED
BID1.20 ASK1.24
Open1.20 Previous Close1.24
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     46.08
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap103.84M 
Earnings Rating
Neutral
Price Range Ratio 52W %
27.91 
Earnings Date
6th Aug 2021

Today's Price Range

1.171.23

52W Range

0.87002.16

5 Year PE Ratio Range

-44.20-9.10

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
1.65%
1 Month
20.59%
3 Months
-0.81%
6 Months
8.85%
1 Year
-26.36%
3 Years
-58.31%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AVCO1.23-0.0100-0.81
AAPL129.64-0.8400-0.64
GOOG2 520.66-6.3800-0.25
MSFT258.36-1.5300-0.59
XOM64.332.26003.64
WFC45.460.31000.69
JNJ164.49-0.8800-0.53
FB336.75-0.0200-0.01
GE13.540.07000.52
JPM155.18-2.3900-1.52
Financial StrengthValueIndustryS&P 500US Markets
3.40
3.90
0.09
0.10
-137.50
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
18.30
-970.70
-931.90
-
-
RevenueValueIndustryS&P 500US Markets
1.03M
0.01
-
-
Earnings HistoryEstimateReportedSurprise %
Q01 2021--0.03-
Q02 2020--0.04-
Q01 2020--0.04-
Q03 2019--0.04-
Q02 2019--0.06-
Q01 2019--0.06-
Q03 2018--0.03-
Q02 2018--0.02-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date6th Aug 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume295.62K
Shares Outstanding84.42M
Trades Count1.15K
Dollar Volume334.44K
Avg. Volume423.98K
Avg. Weekly Volume536.15K
Avg. Monthly Volume329.38K
Avg. Quarterly Volume444.70K

Avalon GloboCare Corp. (NASDAQ: AVCO) stock closed at 1.23 per share at the end of the most recent trading day (a -0.81% change compared to the prior day closing price) with a volume of 296.40K shares and market capitalization of 103.84M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 10 people. Avalon GloboCare Corp. CEO is David Jin.

The one-year performance of Avalon GloboCare Corp. stock is -26.36%, while year-to-date (YTD) performance is 9.82%. AVCO stock has a five-year performance of %. Its 52-week range is between 0.87 and 2.16, which gives AVCO stock a 52-week price range ratio of 27.91%

Avalon GloboCare Corp. currently has a PE ratio of -8.30, a price-to-book (PB) ratio of 22.53, a price-to-sale (PS) ratio of 101.77, a price to cashflow ratio of 2 742.70, a PEG ratio of 2.32, a ROA of -98.48%, a ROC of -120.48% and a ROE of -133.08%. The company’s profit margin is -%, its EBITDA margin is -931.90%, and its revenue ttm is $1.03 Million , which makes it $0.01 revenue per share.

Of the last four earnings reports from Avalon GloboCare Corp., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Avalon GloboCare Corp.’s next earnings report date is 06th Aug 2021.

The consensus rating of Wall Street analysts for Avalon GloboCare Corp. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Avalon GloboCare Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Avalon GloboCare Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Avalon GloboCare Corp. has a Buy technical analysis rating based on Technical Indicators (ADX : 26.78, ATR14 : 0.09, CCI20 : 72.59, Chaikin Money Flow : -0.04, MACD : 0.05, Money Flow Index : 87.22, ROC : 5.13, RSI : 66.49, STOCH (14,3) : 30.61, STOCH RSI : 0.63, UO : 45.47, Williams %R : -69.39), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Avalon GloboCare Corp. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology, and their clinical applications, and healthcare facility management. It has three reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment; and development services and sales of developed products segment. The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

CEO: David Jin

Telephone: 1 (732) 780-4400

Address: 4400 Route 9 South, Freehold 07728, NJ, US

Number of employees: 10

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

43%57%

Bearish Bullish

60%40%

Bearish Bullish

62%38%

News

Stocktwits